Publications by authors named "Michael S Cuoco"

Renal cell carcinoma (RCC) is characterized by recurrent somatic mutations in epigenetic regulators, which stratify patients into clinically significant subgroups with distinct prognoses and treatment responses. However, the cell type-specific epigenetic landscape of RCC-broadly and in the context of these mutations-is incompletely understood. To investigate these open questions, we integrated single nucleus ATAC sequencing data from RCC tumors across four independent cohorts.

View Article and Find Full Text PDF
Article Synopsis
  • - Diabetic kidney disease (DKD) is a major cause of kidney failure linked to diabetes and obesity, but effective treatments to slow its progression are currently unavailable.
  • - Research on single-cell transcriptomic profiles from DKD patients and mouse models reveals a growing population of macrophages expressing TREM2 in mice fed a high-fat diet, which correlates with obesity and diabetes.
  • - In mice lacking TREM2, increased kidney damage and cell injury were observed, indicating that boosting TREM2 macrophages could be a promising therapeutic approach for DKD.
View Article and Find Full Text PDF

Long interspersed nuclear element-1 (L1 or LINE-1) is a highly abundant mobile genetic element in both humans and mice, comprising almost 20% of each genome. L1s are silenced by several mechanisms, as their uncontrolled expression has the potential to induce genomic instability. However, L1s are paradoxically expressed at high levels in differentiating neural progenitor cells.

View Article and Find Full Text PDF
Article Synopsis
  • Disparities for women and minorities in STEM persist despite evidence that diverse teams perform better, leading to the creation of the Diversity and Science Lecture series.
  • This platform showcases junior life scientists discussing their research while emphasizing diversity, equity, and inclusion topics, revealing that most speakers focus on interpersonal support and race/ethnicity issues.
  • The study also highlights less common but important discussions around sexual and gender identities, showing how overlapping identities can shape individual experiences and priorities in STEM, with the goal of enhancing understanding of speaker diversity.
View Article and Find Full Text PDF
Article Synopsis
  • Aneuploidies are changes in the number of chromosomes in cancer cells and are very common.
  • Scientists created a tool called BISCUT to find specific areas in the genome that help cancer cells survive or grow faster.
  • The study discovered important genes related to cancer, including one called WRN, and showed that these chromosome changes are influenced by how much they help or hurt the cells.
View Article and Find Full Text PDF

The mammalian SWI/SNF (mSWI/SNF or BAF) family of chromatin remodeling complexes play critical roles in regulating DNA accessibility and gene expression. The three final-form subcomplexes-cBAF, PBAF, and ncBAF-are distinct in biochemical componentry, chromatin targeting, and roles in disease; however, the contributions of their constituent subunits to gene expression remain incompletely defined. Here, we performed Perturb-seq-based CRISPR-Cas9 knockout screens targeting mSWI/SNF subunits individually and in select combinations, followed by single-cell RNA-seq and SHARE-seq.

View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with limited treatment options, and current methods for understanding its molecular characteristics are inadequate.
  • Researchers used advanced techniques, including single-nucleus RNA sequencing and digital spatial profiling, to analyze 43 PDAC tumors, revealing key cellular subtypes and their interactions.
  • They identified new malignant cell programs linked to poor outcomes and established three distinct multicellular communities, providing insights that could improve patient stratification in clinical trials and guide targeted therapies.
View Article and Find Full Text PDF

Two epigenetic pathways of transcriptional repression, DNA methylation and polycomb repressive complex 2 (PRC2), are known to regulate neuronal development and function. However, their respective contributions to brain maturation are unknown. We found that conditional loss of the de novo DNA methyltransferase in mouse excitatory neurons altered expression of synapse-related genes, stunted synapse maturation, and impaired working memory and social interest.

View Article and Find Full Text PDF

Understanding gene function and regulation in homeostasis and disease requires knowledge of the cellular and tissue contexts in which genes are expressed. Here, we applied four single-nucleus RNA sequencing methods to eight diverse, archived, frozen tissue types from 16 donors and 25 samples, generating a cross-tissue atlas of 209,126 nuclei profiles, which we integrated across tissues, donors, and laboratory methods with a conditional variational autoencoder. Using the resulting cross-tissue atlas, we highlight shared and tissue-specific features of tissue-resident cell populations; identify cell types that might contribute to neuromuscular, metabolic, and immune components of monogenic diseases and the biological processes involved in their pathology; and determine cell types and gene modules that might underlie disease mechanisms for complex traits analyzed by genome-wide association studies.

View Article and Find Full Text PDF

In tumors, a subset of CD8 T cells expressing the transcription factor TCF-1 drives the response to immune checkpoint blockade. We examined the mechanisms that maintain these cells in an autochthonous model of lung adenocarcinoma. Longitudinal sampling and single-cell sequencing of tumor-antigen specific TCF-1 CD8 T cells revealed that while intratumoral TCF-1 CD8 T cells acquired dysfunctional features and decreased in number as tumors progressed, TCF-1 CD8 T cell frequency in the tumor draining LN (dLN) remained stable.

View Article and Find Full Text PDF

Immune responses to cancer are highly variable, with mismatch repair-deficient (MMRd) tumors exhibiting more anti-tumor immunity than mismatch repair-proficient (MMRp) tumors. To understand the rules governing these varied responses, we transcriptionally profiled 371,223 cells from colorectal tumors and adjacent normal tissues of 28 MMRp and 34 MMRd individuals. Analysis of 88 cell subsets and their 204 associated gene expression programs revealed extensive transcriptional and spatial remodeling across tumors.

View Article and Find Full Text PDF
Article Synopsis
  • Non-genetic factors play a crucial role in why some cancer therapies fail, allowing a subset of cancer cells to enter a reversible drug-tolerant state.
  • Researchers developed a tool called Watermelon to trace the origins and behaviors of these resistant cancer cell populations, revealing that cycling and non-cycling persisters come from different lineages with unique metabolic and transcriptional activities.
  • The study found that certain gene programs related to antioxidants and fatty acid metabolism support the ability of these persisters to proliferate, highlighting potential new targets for therapies to improve treatment outcomes and reduce cancer recurrence.
View Article and Find Full Text PDF

Patients with myelodysplastic syndromes (MDSs) display severe anemia but the mechanisms underlying this phenotype are incompletely understood. Right open-reading-frame kinase 2 (RIOK2) encodes a protein kinase located at 5q15, a region frequently lost in patients with MDS del(5q). Here we show that hematopoietic cell-specific haploinsufficient deletion of Riok2 (Riok2Vav1) led to reduced erythroid precursor frequency leading to anemia.

View Article and Find Full Text PDF

Immune checkpoint blockade (ICB) results in durable disease control in a subset of patients with advanced renal cell carcinoma (RCC), but mechanisms driving resistance are poorly understood. We characterize the single-cell transcriptomes of cancer and immune cells from metastatic RCC patients before or after ICB exposure. In responders, subsets of cytotoxic T cells express higher levels of co-inhibitory receptors and effector molecules.

View Article and Find Full Text PDF

Metastatic castration-resistant prostate cancer is typically lethal, exhibiting intrinsic or acquired resistance to second-generation androgen-targeting therapies and minimal response to immune checkpoint inhibitors. Cellular programs driving resistance in both cancer and immune cells remain poorly understood. We present single-cell transcriptomes from 14 patients with advanced prostate cancer, spanning all common metastatic sites.

View Article and Find Full Text PDF

Angiotensin-converting enzyme 2 (ACE2) and accessory proteases (TMPRSS2 and CTSL) are needed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cellular entry, and their expression may shed light on viral tropism and impact across the body. We assessed the cell-type-specific expression of ACE2, TMPRSS2 and CTSL across 107 single-cell RNA-sequencing studies from different tissues. ACE2, TMPRSS2 and CTSL are coexpressed in specific subsets of respiratory epithelial cells in the nasal passages, airways and alveoli, and in cells from other organs associated with coronavirus disease 2019 (COVID-19) transmission or pathology.

View Article and Find Full Text PDF
Article Synopsis
  • - Resistance to immune checkpoint inhibitors (ICIs) in cancer therapy remains a significant obstacle, prompting researchers to develop a new technique called Perturb-CITE-sequencing (Perturb-CITE-seq) to investigate this issue.
  • - The study analyzed over 218,000 patient-derived melanoma cells and tumor-infiltrating lymphocyte co-cultures, identifying known and new mechanisms of immune resistance, including defects in specific signaling pathways and the downregulation of a protein called CD58.
  • - CD58 loss was linked to immune evasion in melanoma, and interestingly, its expression wasn't affected by interferon-γ signaling, indicating it interacts differently than previously known resistance mechanisms, thus paving the way for better understanding
View Article and Find Full Text PDF
Article Synopsis
  • Synovial sarcoma (SyS) is an aggressive cancer driven by the SS18-SSX fusion, showing low levels of T cell infiltration, which indicates immune evasion.
  • Researchers used single-cell RNA sequencing to analyze 16,872 cells from human SyS tumors, identifying a key malignant subpopulation linked to poorer clinical outcomes and immune-deprived areas.
  • The study found that the malignant cell state is influenced by the SS18-SSX fusion and can be targeted with a combination of HDAC and CDK4/CDK6 inhibitors, boosting T cell responses and enhancing treatment effectiveness.
View Article and Find Full Text PDF

Cultured cell lines are the workhorse of cancer research, but the extent to which they recapitulate the heterogeneity observed among malignant cells in tumors is unclear. Here we used multiplexed single-cell RNA-seq to profile 198 cancer cell lines from 22 cancer types. We identified 12 expression programs that are recurrently heterogeneous within multiple cancer cell lines.

View Article and Find Full Text PDF
Article Synopsis
  • The enteric nervous system (ENS) plays a crucial role in intestinal functions but has been challenging to study due to the rare and diverse nature of its cells.
  • Researchers developed two innovative methods, RAISIN RNA-seq and MIRACL-seq, to analyze individual cells in the ENS of adult mice and humans, revealing a high diversity of neurons and significant gene expression changes related to age and disease.
  • The study highlighted differences in neuronal profiles between the intestine regions and found that the human ENS expresses genes linked to various diseases, indicating a potential role of these neurons in health issues.
View Article and Find Full Text PDF

Purpose: To identify clinically relevant mechanisms of resistance to ER-directed therapies in ER breast cancer.

Experimental Design: We conducted a genome-scale functional screen spanning 10,135 genes to investigate genes whose overexpression confer resistance to selective estrogen receptor degraders. In parallel, we performed whole-exome sequencing in paired pretreatment and postresistance biopsies from 60 patients with ER metastatic breast cancer who had developed resistance to ER-targeted therapy.

View Article and Find Full Text PDF

Malignant abdominal fluid (ascites) frequently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associated with drug resistance and a poor prognosis. To comprehensively characterize the HGSOC ascites ecosystem, we used single-cell RNA sequencing to profile ~11,000 cells from 22 ascites specimens from 11 patients with HGSOC. We found significant inter-patient variability in the composition and functional programs of ascites cells, including immunomodulatory fibroblast sub-populations and dichotomous macrophage populations.

View Article and Find Full Text PDF

Regulatory T cells (T) can impair anti-tumor immune responses and are associated with poor prognosis in multiple cancer types. T in human tumors span diverse transcriptional states distinct from those of peripheral T, but their contribution to tumor development remains unknown. Here, we use single-cell RNA sequencing (RNA-seq) to longitudinally profile dynamic shifts in the distribution of T in a genetically engineered mouse model of lung adenocarcinoma.

View Article and Find Full Text PDF
Article Synopsis
  • Seventy percent of breast cancers are estrogen receptor-positive (ER+), with treatments targeting the ER being standard; however, resistance to these treatments often develops in metastatic cases.* -
  • Research identified activating HER2 mutations in eight ER+ metastatic breast cancer patients who became resistant to common therapies, suggesting these mutations were acquired during treatment rather than present beforehand.* -
  • The identified HER2 mutations led to estrogen independence and distinct resistance mechanisms, but treatment effectiveness improved when combining ER-directed therapy with the HER2 inhibitor neratinib.*
View Article and Find Full Text PDF